deferoxamine has been researched along with Centriacinar Emphysema in 2 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pasupneti, S | 1 |
| Tian, W | 1 |
| Tu, AB | 1 |
| Dahms, P | 1 |
| Granucci, E | 1 |
| Gandjeva, A | 1 |
| Xiang, M | 1 |
| Butcher, EC | 1 |
| Semenza, GL | 1 |
| Tuder, RM | 1 |
| Jiang, X | 1 |
| Nicolls, MR | 1 |
2 other studies available for deferoxamine and Centriacinar Emphysema
| Article | Year |
|---|---|
Endothelial HIF-2α as a Key Endogenous Mediator Preventing Emphysema.
Topics: Angiogenesis Inhibitors; Animals; Basic Helix-Loop-Helix Transcription Factors; Deferoxamine; Diseas | 2020 |
Research findings of potential value to the practitioner.
Topics: Bronchitis; Chronic Disease; Deferoxamine; Diagnosis, Differential; Hematologic Diseases; Injections | 1977 |